Rahul Joshi

Unosource Pharma Ltd.

Uno Source is committed to improving the health of patients worldwide through development, production and marketing of innovative pharmaceutical products. We are dedicated to ensuring that our research, development strategy and results are conducted in a transparent and shared way and in a collaborative manner with researchers, health authorities and especially patients. Our specialized in-house and DSIR recognized unit is the backbone of the company. Our state-of-the -art, sophisticated lab is well-equipped which help us develop quality products for the healthcare industry. We pursue robust organic growth. This strategy is complemented by key alliances with exemplary global marketing partners. We strive towards better health for patients worldwide through leading innovation in medicine, distinctive marketing capabilities, state of the art manufacturing facilities, broad product portfolio, deep understanding of pharmaceutical regulations, and strong partnerships and affiliations,. As a recognized WHO GMP approved/PICS compliant manufacturer for pharmaceuticals, we endeavor to stick to WHO / PICS quality standards. We have a comprehensive presence in the global marketplace, with our formulations available in more than 25 countries worldwide. Our eight state-of-the-art manufacturing facilities enable us to produce more than 5000 plus bioequivalence finished formulations (medicines), which are accredited and approved by various regulatory authorities across the globe. Our female hormone facility and injectable / ophthalmic plants are USFDA / PICS compliant. Also, our state-of-the-art, one of the largest across the globe stability center, provides outstanding stability testing performance for manufacturing of pharmaceuticals. Our focus is on innovating the future through the development of new health products and to make them available at all pharmacies worldwide.